These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35689262)

  • 81. Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
    Qian XL; Xu P; Zhang YQ; Song YM; Li YQ; Li WD; Jiang CY; Shen BB; Zhang XM; Zhang LN; Fu L; Guo XJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):311-319. PubMed ID: 31993861
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
    Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
    ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
    Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
    Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 87. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
    Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
    Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Novel anti-VEGFR2 antibody-conjugated nanobubbles for targeted ultrasound molecular imaging in a rabbit VX2 hepatic tumor model.
    Yu H; Zheng S; Wang C; Xing J; Li L
    J Mater Chem B; 2023 Nov; 11(45):10956-10966. PubMed ID: 37942841
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer.
    Cao Y; Yu X; Zeng T; Fu Z; Zhao Y; Nie B; Zhao J; Yin Y; Li G
    J Am Chem Soc; 2022 Aug; 144(30):13475-13486. PubMed ID: 35802880
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nanobody-loaded nanobubbles targeting the G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC.
    Chen J; Li J; Zhong C; Ling Y; Liu D; Li X; Xu J; Liu Q; Guo Y; Wang L
    Nanoscale; 2023 Dec; 16(1):343-359. PubMed ID: 38062769
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Functional evaluation of constructed pseudo-endogenous microRNA-targeted myocardial ultrasound nanobubble.
    Ainiwan A; Wei Y; Dou J; Tang L; Mu Y; Guan L
    Front Med (Lausanne); 2023; 10():1136304. PubMed ID: 37809333
    [TBL] [Abstract][Full Text] [Related]  

  • 94. In Situ Insonation of Alkaline Buffer Containing Liposomes Leads to a Net Improvement of the Therapeutic Outcome in a Triple Negative Breast Cancer Murine Model.
    Patrucco D; Cutrin JC; Longo DL; Botto E; Cong L; Aime S; Delli Castelli D
    Adv Healthc Mater; 2023 Dec; 12(32):e2301480. PubMed ID: 37709294
    [TBL] [Abstract][Full Text] [Related]  

  • 95. All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.
    Luo Z; Wu S; Zhou J; Xu W; Xu Q; Lu L; Xie C; Liu Y; Lu W
    Acta Pharm Sin B; 2023 Jan; 13(1):359-371. PubMed ID: 36815053
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Universal endogenous antibody recruiting nanobodies capable of triggering immune effectors for targeted cancer immunotherapy.
    Hong H; Li C; Gong L; Wang J; Li D; Shi J; Zhou Z; Huang Z; Wu Z
    Chem Sci; 2021 Feb; 12(12):4623-4630. PubMed ID: 34163726
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Development of an Antibody Delivery Method for Cancer Treatment by Combining Ultrasound with Therapeutic Antibody-Modified Nanobubbles Using Fc-Binding Polypeptide.
    Yano Y; Hamano N; Haruta K; Kobayashi T; Sato M; Kikkawa Y; Endo-Takahashi Y; Tada R; Suzuki R; Maruyama K; Nomizu M; Negishi Y
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678759
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A dual-targeting therapeutic nanobubble for imaging-guided atherosclerosis treatment.
    Lin J; Chen X; Li Y; Yu L; Chen Y; Zhang B
    Mater Today Bio; 2024 Jun; 26():101037. PubMed ID: 38586870
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efficient mRNA Delivery with Lyophilized Human Serum Albumin-Based Nanobubbles.
    Kida H; Yamasaki Y; Feril LB; Endo H; Itaka K; Tachibana K
    Nanomaterials (Basel); 2023 Apr; 13(7):. PubMed ID: 37049376
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound.
    Koga T; Kida H; Yamasaki Y; Feril LB; Endo H; Itaka K; Abe H; Tachibana K
    Nanomaterials (Basel); 2024 Jan; 14(3):. PubMed ID: 38334557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.